Lovesac Q1 FY26 Results: Net Sales Rise 4.3% to $138.4M, Net Loss Narrows 16.4% to $10.8M, EPS Improves 12% to $(0.73)

Reuters
2025/06/12
Lovesac Q1 FY26 Results: Net Sales Rise 4.3% to $138.4M, Net Loss Narrows 16.4% to $10.8M, EPS Improves 12% to $(0.73)

The Lovesac Company reported a 4.3% increase in net sales for the first quarter of fiscal 2026, reaching $138.4 million compared to $132.6 million in the same period of fiscal 2025. Showroom sales saw a significant rise of 18.2%, totaling $96.5 million, while internet sales decreased by 8.9% to $33.3 million. Other sales categories experienced a 40.5% decline, amounting to $8.6 million. The company reported a net loss of $10.8 million, an improvement of 16.4% from the $13.0 million loss reported in the first quarter of the previous fiscal year. Gross profit increased by 3.2% to $74.4 million, with a slight decrease in gross margin to 53.7%. Lovesac's CEO, Shawn Nelson, highlighted the launch of the company's third Designed For Life Platform, EverCouch, which expands their product offerings into the armchair, loveseat, and sofa category, effectively doubling the company's total addressable market. The company expressed confidence in its long-term growth trajectory despite the challenging economic environment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lovesac Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-030859), on June 12, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10